Replies to post #11324 on CryoPort Inc (CYRX)

[mikeslife]

I show $218,000 in first quarter revenue from Gilead and Novartis based on 52 million in sales. 40 million from Yescarta and 12 million from Kymriah.

[coldasice]

Hyper would be correct. So CYRX should make about 513k, give or take this quarter, just on those 2 commercializations alone.
According to the companies last conference call, net 236 clinical trials.
15k -75k phase one revenue estimation, 75k-150k phase two revenue estimation and phase three ,200k to 1 million.. What would be the average cost per clinical trial(236) per quarter? HYPER, I'm sure you will come up with the answer. My conservative estimate would be taking the low range of phase 1, 15k.. That's 3.5 million or so.. Add in the 513k, close to 4 million, without IVF, animal health and other bells and whistles..

I see Fred Alger owns close to 9.9 percent of CYRX, around 43 million dollars worth of stock.. Robert what are your thoughts on this institution.